Assembling intelligence…
IGF::OT::IGF ID/IQ PARENT AWARD FOR PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS - PPD DEVELOPMENT, LP
| Company | Orders | Obligated | Latest order end |
|---|---|---|---|
| PPD DEVELOPMENT LP | 7 | $9.1M | 2027-04-28 |
| 75N95024F00001 PPD DEVELOPMENT LP · National Institutes of Health | $2.8M | 2026-06-30 |
| 75N95019F00088 PPD DEVELOPMENT LP · National Institutes of Health | $1.9M | 2021-09-11 |
| 75N95019F00089 PPD DEVELOPMENT LP · National Institutes of Health | $1.8M | 2025-03-10 |
| 75N95018F00002 PPD DEVELOPMENT LP · National Institutes of Health | $1.7M | 2020-08-30 |
| HHSN27100001 PPD DEVELOPMENT LP · National Institutes of Health | $434K | 2024-06-30 |